Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH8 DNAH10 DNAH1 DNAH12	3.49e-05	18	214	4	GO:0008569
GeneOntologyCellularComponent	inner dynein arm	DNAH10 DNAI3 DNAH1 DNAH12	2.14e-06	10	214	4	GO:0036156
GeneOntologyCellularComponent	axonemal dynein complex	DNAH8 DNAH10 DNAI3 DNAH1 DNAH12	4.82e-06	25	214	5	GO:0005858
GeneOntologyCellularComponent	dynein complex	DCTN1 DNAH8 DNAH10 DNAI3 DNAH1 DNAH12	1.84e-05	54	214	6	GO:0030286
Domain	Nxph	NXPH1 NXPH4 NXPH2	5.64e-06	4	211	3	IPR010450
Domain	Dynein_heavy_chain_D4_dom	DNAH8 DNAH10 DNAH1 DNAH12	1.45e-05	14	211	4	IPR024317
Domain	Dynein_heavy_dom-2	DNAH8 DNAH10 DNAH1 DNAH12	1.45e-05	14	211	4	IPR013602
Domain	DHC_N2	DNAH8 DNAH10 DNAH1 DNAH12	1.45e-05	14	211	4	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH8 DNAH10 DNAH1 DNAH12	1.45e-05	14	211	4	IPR011704
Domain	AAA_8	DNAH8 DNAH10 DNAH1 DNAH12	1.45e-05	14	211	4	PF12780
Domain	AAA_5	DNAH8 DNAH10 DNAH1 DNAH12	1.45e-05	14	211	4	PF07728
Domain	DHC_fam	DNAH8 DNAH10 DNAH1 DNAH12	1.96e-05	15	211	4	IPR026983
Domain	Dynein_heavy	DNAH8 DNAH10 DNAH1 DNAH12	1.96e-05	15	211	4	PF03028
Domain	Dynein_heavy_dom	DNAH8 DNAH10 DNAH1 DNAH12	1.96e-05	15	211	4	IPR004273
Domain	Neurexophilin	NXPH1 NXPH4 NXPH2	7.63e-05	8	211	3	PF06312
Domain	NXPH/NXPE	NXPH1 NXPH4 NXPH2	7.63e-05	8	211	3	IPR026845
Domain	PH_dom-like	NUP50 MYO10 PLEKHS1 EPB41L4A FARP2 JAK2 RTKN2 OSBP2 PLCB4 MAPK8IP1 WAS NBEA SPTBN4 OSBP LRBA	1.06e-04	426	211	15	IPR011993
Domain	Ufd2P_core	UBE4B UBE4A	1.27e-04	2	211	2	PF10408
Domain	-	SYK ZAP70	1.27e-04	2	211	2	1.10.930.10
Domain	Kinase_SYK/ZAP-70_inter-SH2	SYK ZAP70	1.27e-04	2	211	2	IPR023420
Domain	DUF1088	NBEA LRBA	1.27e-04	2	211	2	IPR010508
Domain	Tyr_kinase_non-rcpt_SYK/ZAP70	SYK ZAP70	1.27e-04	2	211	2	IPR012234
Domain	Ub_conjug_fac_E4_core	UBE4B UBE4A	1.27e-04	2	211	2	IPR019474
Domain	DUF1088	NBEA LRBA	1.27e-04	2	211	2	PF06469
Domain	FERM_central	MYO10 EPB41L4A FARP2 JAK2 MYO15A	2.23e-04	49	211	5	IPR019748
Domain	FERM_domain	MYO10 EPB41L4A FARP2 JAK2 MYO15A	2.23e-04	49	211	5	IPR000299
Domain	FERM_1	MYO10 EPB41L4A FARP2 JAK2 MYO15A	2.46e-04	50	211	5	PS00660
Domain	FERM_2	MYO10 EPB41L4A FARP2 JAK2 MYO15A	2.46e-04	50	211	5	PS00661
Domain	FERM_3	MYO10 EPB41L4A FARP2 JAK2 MYO15A	2.46e-04	50	211	5	PS50057
Domain	Band_41_domain	MYO10 EPB41L4A FARP2 JAK2 MYO15A	2.46e-04	50	211	5	IPR019749
Domain	B41	MYO10 EPB41L4A FARP2 JAK2 MYO15A	2.46e-04	50	211	5	SM00295
Domain	Dynein_HC_stalk	DNAH8 DNAH10 DNAH1	4.72e-04	14	211	3	IPR024743
Domain	MT	DNAH8 DNAH10 DNAH1	4.72e-04	14	211	3	PF12777
Domain	Nicotinic_acetylcholine_rcpt	CHRNA2 CHRNA3 CHRNB4	7.14e-04	16	211	3	IPR002394
Domain	DUF3504	QRICH1 ZMYM3	1.24e-03	5	211	2	IPR021893
Domain	DUF4704	NBEA LRBA	1.24e-03	5	211	2	IPR031570
Domain	DUF4704	NBEA LRBA	1.24e-03	5	211	2	PF15787
Domain	DUF3504	QRICH1 ZMYM3	1.24e-03	5	211	2	PF12012
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DCTN1 DNAH8 DNAH10 DNAH1 DNAH12	1.20e-05	27	161	5	M47755
Pathway	KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B JAK2	1.44e-05	5	161	3	M49006
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5	STAT5A STAT5B JAK2	4.95e-05	7	161	3	M27907
Pathway	KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B JAK2	4.95e-05	7	161	3	M47646
Pathway	PID_GMCSF_PATHWAY	STAT5A STAT5B JAK2 SYK YWHAZ	5.17e-05	36	161	5	M22
Pathway	REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING	STAT5A STAT5B JAK2 SYK YWHAZ	9.82e-05	41	161	5	MM15162
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA3 CHRNB4	1.17e-04	9	161	3	M27597
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA3 CHRNB4	1.17e-04	9	161	3	MM15313
Pathway	BIOCARTA_IL22BP_PATHWAY	STAT5A STAT5B JAK2	1.17e-04	9	161	3	M8066
Pathway	BIOCARTA_IL22BP_PATHWAY	STAT5A STAT5B JAK2	1.17e-04	9	161	3	MM1419
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DCTN1 DNAH8 DNAH10 DNAH1 DNAH12	1.24e-04	43	161	5	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DCTN1 DNAH8 DNAH10 DNAH1 DNAH12	1.54e-04	45	161	5	M47670
Pathway	REACTOME_INTERLEUKIN_2_SIGNALING	STAT5A STAT5B SYK	1.65e-04	10	161	3	MM15618
Pathway	REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING	STAT5A STAT5B JAK2 SYK	1.72e-04	25	161	4	M41829
Pathway	PID_IL3_PATHWAY	STAT5A STAT5B JAK2 YWHAZ	2.01e-04	26	161	4	M182
Pathway	REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING	STAT5A STAT5B JAK2 SYK YWHAZ	2.10e-04	48	161	5	M914
Pathway	REACTOME_SIGNALING_BY_LEPTIN	STAT5A STAT5B JAK2	2.26e-04	11	161	3	M27195
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA3 CHRNB4	2.26e-04	11	161	3	M883
Pathway	REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA3 CHRNB4	2.98e-04	12	161	3	M48008
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA3 CHRNB4	2.98e-04	12	161	3	MM15312
Pathway	REACTOME_INTERLEUKIN_2_SIGNALING	STAT5A STAT5B SYK	2.98e-04	12	161	3	M27893
Pathway	REACTOME_SIGNALING_BY_CSF3_G_CSF	STAT5A STAT5B JAK2 SYK	3.56e-04	30	161	4	M41825
Pathway	PID_IL5_PATHWAY	STAT5A STAT5B JAK2	4.85e-04	14	161	3	M135
Pathway	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	CHRNA2 CHRNA3 CHRNB4	4.85e-04	14	161	3	M757
Pathway	REACTOME_PROLACTIN_RECEPTOR_SIGNALING	STAT5A STAT5B JAK2	6.01e-04	15	161	3	M552
Pathway	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	CHRNA2 CHRNA3 CHRNB4	6.01e-04	15	161	3	MM14704
Pathway	BIOCARTA_IL3_PATHWAY	STAT5A STAT5B JAK2	6.01e-04	15	161	3	MM1412
Pathway	BIOCARTA_IL3_PATHWAY	STAT5A STAT5B JAK2	6.01e-04	15	161	3	M17681
Pathway	REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING	STAT5A STAT5B JAK2 SYK	6.51e-04	35	161	4	MM15144
Pathway	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	STAT5A STAT5B JAK2	7.34e-04	16	161	3	MM15710
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIVEP2 MYO5A UBE4B TTC21A ETV1 PFKFB4 SLC30A4 HP1BP3 STAT5B FARP2 JAK2 TMEM184A SGSM2 SEL1L3 CACNA1H FGF13 PLCB4 GNAZ UBR2 RHBDD1 STXBP5L DNAH1 SPTBN4 IGF1R THRB PLPP1 NACC2 LPP WDR45B IFT122 LRBA PAN3 NXPH4 VPS13B EVI5L ZNF44	2.76e-12	1489	216	36	28611215
Pubmed	Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.	STAT5A STAT5B JAK2	2.36e-07	3	216	3	26362718
Pubmed	Critical requirement for Stat5 in a mouse model of polycythemia vera.	STAT5A STAT5B JAK2	2.36e-07	3	216	3	22144185
Pubmed	Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling.	STAT5A STAT5B IGF1R	2.36e-07	3	216	3	20133448
Pubmed	Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.	STAT5A STAT5B JAK2	2.36e-07	3	216	3	15016718
Pubmed	Thrombopoietin controls proliferation of embryonic multipotent hematopoietic progenitors.	STAT5A STAT5B JAK2	2.36e-07	3	216	3	19500160
Pubmed	Jak2-Stat5 interactions analyzed in yeast.	STAT5A STAT5B JAK2	2.36e-07	3	216	3	9575217
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	MYO5A SERPINB8 PLAU C5 GP1BA GP2 DPP4 SELENOP CP XPNPEP1 SLC44A4 YWHAZ ACTR3 SPTBN4 SLC12A1 P2RX4 RNPEP TBC1D10A PLPP1 PEBP1 RNASET2 FUCA1 CTSL	2.69e-07	1070	216	23	23533145
Pubmed	Multiple mouse chromosomal loci for dynein-based motility.	NEB DCTN1 PLAU DNAH8 DNAH1 DNAH12	4.65e-07	47	216	6	8812413
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	KIFBP IQGAP2 TM9SF3 MCM6 QRICH1 DCTN1 RXRB GTF3C3 TRAPPC13 UBE4A DEK DHX16 UBR2 KAT5 L3MBTL2 NCOR1 RIF1 NACC2 ZMYM3 SMAD2	4.78e-07	857	216	20	25609649
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SF3B4 HIVEP2 MYO5A UBE4B ZNF423 QRICH1 DCTD DCTN1 STAT5B UBE4A CLK1 SGSM2 KCNN1 MED13 MAPK8IP1 ARFGEF2 NBEA YWHAZ ADAM22 SPTBN4 ZNF92 IFT122 LRBA CTSL SMAD2	5.03e-07	1285	216	25	35914814
Pubmed	Loss of JAK1 Drives Innate Immune Deficiency.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	30671064
Pubmed	Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	23406773
Pubmed	Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	18424709
Pubmed	Constitutive STAT5 activation regulates Paneth and Paneth-like cells to control Clostridium difficile colitis.	STAT5A STAT5B LGR5	9.41e-07	4	216	3	30948494
Pubmed	Effects of hyperactive Janus kinase 2 signaling in mammary epithelial cells.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	12147240
Pubmed	ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	19571317
Pubmed	Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	9657743
Pubmed	Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	18239084
Pubmed	Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.	STAT5A STAT5B JAK2	9.41e-07	4	216	3	17639043
Pubmed	Polychlorinated biphenyls suppress thyroid hormone receptor-mediated transcription through a novel mechanism.	RXRB NCOR1 THRB	9.41e-07	4	216	3	14985366
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NUP50 DDX19A TM9SF3 MCM6 QRICH1 DCTD PLAU DEK XPNPEP1 NCOR1 RIF1 PEBP1 SENP2 CTSL	1.21e-06	457	216	14	32344865
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH8 DNAH10 DNAH1 DNAH12	1.38e-06	14	216	4	9373155
Pubmed	Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice.	STAT5A STAT5B JAK2	2.34e-06	5	216	3	22234689
Pubmed	Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway.	STAT5A STAT5B JAK2	2.34e-06	5	216	3	11440634
Pubmed	An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.	STAT5A STAT5B JAK2	2.34e-06	5	216	3	9047382
Pubmed	Neurexophilins form a conserved family of neuropeptide-like glycoproteins.	NXPH1 NXPH4 NXPH2	2.34e-06	5	216	3	9570794
Pubmed	Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.	STAT5A STAT5B JAK2	2.34e-06	5	216	3	12456798
Pubmed	PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.	STAT5A STAT5B JAK2	2.34e-06	5	216	3	11923474
Pubmed	SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.	STAT5A STAT5B JAK2 SENP2	4.14e-06	18	216	4	17981124
Pubmed	Stat5 expression is critical for mast cell development and survival.	STAT5A STAT5B IL1RL1	4.66e-06	6	216	3	12714518
Pubmed	Proteotyping of mammary tissue from transgenic and gene knockout mice with immunohistochemical markers: a tool to define developmental lesions.	STAT5A STAT5B JAK2	4.66e-06	6	216	3	12704203
Pubmed	Fatty acid transport protein 2 reprograms neutrophils in cancer.	STAT5A STAT5B SLC27A4	4.66e-06	6	216	3	30996346
Pubmed	Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells.	STAT5A STAT5B ZAP70	8.12e-06	7	216	3	20118929
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH8 DNAH1 DNAH12	8.12e-06	7	216	3	9256245
Pubmed	Neurexophilin binding to alpha-neurexins. A single LNS domain functions as an independently folding ligand-binding unit.	NXPH1 NXPH4 NXPH2	8.12e-06	7	216	3	9856994
Pubmed	Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans.	CHRNA2 CHRNA3 CHRNB4	8.12e-06	7	216	3	1505988
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UBE4B MYO10 ZNF423 FSTL5 SGSM2 SEL1L3 CACNA1H DHX16 UBR2 SENP2 VPS13B ZMYM3	1.04e-05	407	216	12	12693553
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NEB TGM5 STAT5A HP1BP3 SCAF4 PLCB4 COPS6 NBEA IGF1R DNAH12 ZNF540 USP39 LRBA	1.58e-05	497	216	13	36774506
Pubmed	The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses.	STAT5A STAT5B JAK2	1.93e-05	9	216	3	23435120
Pubmed	Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.	CHRNA2 CHRNA3 CHRNB4	1.93e-05	9	216	3	8906617
Pubmed	The Jak-STAT pathway.	STAT5A STAT5B JAK2	1.93e-05	9	216	3	10781830
Pubmed	IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.	STAT5A STAT5B IL1R1	1.93e-05	9	216	3	25642823
Pubmed	Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.	STAT5A STAT5B JAK2	1.93e-05	9	216	3	9484840
Pubmed	3,400 new expressed sequence tags identify diversity of transcripts in human brain.	FSTL5 EPB41L4A SLC27A4	1.93e-05	9	216	3	8358434
Pubmed	Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.	STAT5A STAT5B JAK2	2.75e-05	10	216	3	20974963
Pubmed	Cytokines, Jaks, Stats, health and disease.	STAT5A STAT5B JAK2	2.75e-05	10	216	3	10200816
Pubmed	Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence.	CHRNA2 CHRNA3 CHRNB4	2.75e-05	10	216	3	20736995
Pubmed	JAK-STAT and bone metabolism.	STAT5A STAT5B JAK2	2.75e-05	10	216	3	24069548
Pubmed	Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines.	CHRNA2 CHRNA3 CHRNB4	2.75e-05	10	216	3	10336173
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	IQGAP2 MYO5A DCTN1 SH3KBP1 NBEA YWHAZ ADAM22 SPTBN4 PLPP3	3.00e-05	251	216	9	27507650
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	NUP50 DDX19A KIFBP TM9SF3 MCM6 RPS25 DCTN1 GTF3C3 UBE4A STIP1 TDRD6 DEK PLXNA1 SLC27A4 DHX16 NRDC DNAH10 KRR1 ACTR3 RIF1 RNPEP PEBP1 USP39	3.02e-05	1425	216	23	30948266
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	MYO10 ZNF423 QRICH1 SCAF4 SYK PLCB4 PPIP5K2 MED13 C2orf76 NCOR1 RIF1 LPP PTCD2	3.47e-05	536	216	13	15840001
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	SETD1A KIFBP MYO5A MYO10 PDZK1 PFKFB4 DCTN1 HP1BP3 FARP2 ABRAXAS2 CLK1 WNT16 L3MBTL2 ACBD5 XPNPEP1 GPC6 MOSPD1 TBC1D10A NACC2 MYO15A VPS53	3.51e-05	1242	216	21	30973865
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	MYO10 ZNF423 QRICH1 SCAF4 SYK PLCB4 PPIP5K2 MED13 C2orf76 NCOR1 RIF1 LPP PTCD2	3.60e-05	538	216	13	10512203
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ELOA2 IQGAP2 MYO5A TM9SF3 ANKRD30B RPS25 NEB DCTN1 FER1L6 HP1BP3 GPC4 PPIP5K2 DNAH8 MED13 SLC27A4 YWHAZ ACTR3 SPTBN4 CCDC27 NCOR1 IFT122 NOSTRIN IL1R1	3.63e-05	1442	216	23	35575683
Pubmed	Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus.	CHRNA2 CHRNA3 CHRNB4	3.76e-05	11	216	3	12225896
Pubmed	Definitive evidence using enucleated cytoplasts for a nongenomic basis for the cystic change in endoplasmic reticulum structure caused by STAT5a/b siRNAs.	STAT5A STAT5B	3.84e-05	2	216	2	23151802
Pubmed	SENP2-PLCβ4 signaling regulates neurogenesis through the maintenance of calcium homeostasis.	PLCB4 SENP2	3.84e-05	2	216	2	34465891
Pubmed	A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions.	STAT5A STAT5B	3.84e-05	2	216	2	31443474
Pubmed	Miniglucagon (MG)-generating endopeptidase, which processes glucagon into MG, is composed of N-arginine dibasic convertase and aminopeptidase B.	NRDC RNPEP	3.84e-05	2	216	2	15539558
Pubmed	Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4.	CHRNA3 CHRNB4	3.84e-05	2	216	2	11450844
Pubmed	SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.	SYK ZAP70	3.84e-05	2	216	2	35398488
Pubmed	Fly and mammalian lipid phosphate phosphatase isoforms differ in activity both in vitro and in vivo.	PLPP1 PLPP3	3.84e-05	2	216	2	12856002
Pubmed	The detection of tumor location and lymph node metastasis by aberrant NXPH1 and NXPH2 expressions in pancreatic ductal adenocarcinomas.	NXPH1 NXPH2	3.84e-05	2	216	2	27817196
Pubmed	Contribution of P2X4 Receptors to CNS Function and Pathophysiology.	P2RX4 P2RY1	3.84e-05	2	216	2	32756482
Pubmed	A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development.	STAT5A STAT5B	3.84e-05	2	216	2	21127177
Pubmed	The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.	STAT5A STAT5B	3.84e-05	2	216	2	16289657
Pubmed	Deletion of STAT5a/b in vascular smooth muscle abrogates the male bias in hypoxic pulmonary hypertension in mice: implications in the human disease.	STAT5A STAT5B	3.84e-05	2	216	2	25470773
Pubmed	Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.	JAK2 SYK	3.84e-05	2	216	2	24486434
Pubmed	Differential selectivity of JAK2 inhibitors in enzymatic and cellular settings.	STAT5A JAK2	3.84e-05	2	216	2	23340136
Pubmed	Constitutively active Stat5A and Stat5B promote adipogenesis.	STAT5A STAT5B	3.84e-05	2	216	2	21431790
Pubmed	Nicotinic receptor-mediated filtering of mitral cell responses to olfactory nerve inputs involves the α3β4 subtype.	CHRNA3 CHRNB4	3.84e-05	2	216	2	22378897
Pubmed	JIP1 regulates the directionality of APP axonal transport by coordinating kinesin and dynein motors.	DCTN1 MAPK8IP1	3.84e-05	2	216	2	23897889
Pubmed	Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs.	STAT5A STAT5B	3.84e-05	2	216	2	7720707
Pubmed	Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases.	SYK ZAP70	3.84e-05	2	216	2	11836527
Pubmed	A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer.	IL1RL1 IL1R1	3.84e-05	2	216	2	15481335
Pubmed	T-cell receptor-induced phosphorylation of the zeta chain is efficiently promoted by ZAP-70 but not Syk.	SYK ZAP70	3.84e-05	2	216	2	15059847
Pubmed	Stat5: an essential regulator of mast cell biology.	STAT5A STAT5B	3.84e-05	2	216	2	12217382
Pubmed	Brain STAT5 Modulates Long-Term Metabolic and Epigenetic Changes Induced by Pregnancy and Lactation in Female Mice.	STAT5A STAT5B	3.84e-05	2	216	2	31599926
Pubmed	DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.	STAT5A STAT5B	3.84e-05	2	216	2	10594041
Pubmed	Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells.	STAT5A STAT5B	3.84e-05	2	216	2	21036145
Pubmed	Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice.	STAT5A STAT5B	3.84e-05	2	216	2	10486277
Pubmed	Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.	SYK ZAP70	3.84e-05	2	216	2	19297020
Pubmed	The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.	STAT5A STAT5B	3.84e-05	2	216	2	15128421
Pubmed	STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.	STAT5A STAT5B	3.84e-05	2	216	2	30377054
Pubmed	Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung.	STAT5A STAT5B	3.84e-05	2	216	2	23565285
Pubmed	The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice.	CHRNA3 CHRNB4	3.84e-05	2	216	2	15275829
Pubmed	Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells.	STAT5A STAT5B	3.84e-05	2	216	2	23773921
Pubmed	Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear.	CHRNA2 CHRNB4	3.84e-05	2	216	2	16826524
Pubmed	Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population.	STAT5A STAT5B	3.84e-05	2	216	2	24878107
Pubmed	A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking.	MRC2 PLAU	3.84e-05	2	216	2	7904248
Pubmed	Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.	STAT5A STAT5B	3.84e-05	2	216	2	7568026
Pubmed	Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron.	SLC12A1 IL1R1	3.84e-05	2	216	2	26712462
Pubmed	STAT5 signaling in sexually dimorphic gene expression and growth patterns.	STAT5A STAT5B	3.84e-05	2	216	2	10486314
Pubmed	Differential localization of lipid phosphate phosphatases 1 and 3 to cell surface subdomains in polarized MDCK cells.	PLPP1 PLPP3	3.84e-05	2	216	2	14527693
Pubmed	Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia.	STAT5A STAT5B	3.84e-05	2	216	2	24335105
Pubmed	Brain STAT5 signaling modulates learning and memory formation.	STAT5A STAT5B	3.84e-05	2	216	2	29460051
Pubmed	ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1.	IL1RL1 IL1R1	3.84e-05	2	216	2	7499265
Pubmed	Tyrosine kinase SYK: essential functions for immunoreceptor signalling.	SYK ZAP70	3.84e-05	2	216	2	10689303
Interaction	KNG1 interactions	UBE2U MRC2 COPS6 GP1BA RHBDD1 PHF11 CTSL	4.20e-06	63	211	7	int:KNG1
Cytoband	2q12	ZAP70 IL1RL1 IL1R1	2.19e-05	12	216	3	2q12
GeneFamily	Dyneins, axonemal	DNAH8 DNAH10 DNAH1 DNAH12	1.38e-05	17	163	4	536
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO10 EPB41L4A FARP2 JAK2 MYO15A	8.55e-05	50	163	5	1293
GeneFamily	Cholinergic receptors nicotinic subunits	CHRNA2 CHRNA3 CHRNB4	3.70e-04	16	163	3	173
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	HIVEP2 ZNF423 ZNF518A ZNF599 ZNF763 ZFP62 ZNF823 ZNF519 ZNF19 CTCFL ZNF92 ZNF540 ZNF799 ZNF761 ZNF518B ZNF44	7.90e-04	718	163	16	28
GeneFamily	Glypicans	GPC4 GPC6	1.18e-03	6	163	2	572
GeneFamily	U-box domain containing	UBE4B UBE4A	1.65e-03	7	163	2	365
GeneFamily	Phospholipid phosphatases	PLPP1 PLPP3	1.65e-03	7	163	2	1067
GeneFamily	SH2 domain containing	STAT5A STAT5B JAK2 SYK ZAP70	2.21e-03	101	163	5	741
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	MYO10 PLEKHS1 FARP2 RTKN2 OSBP2 SPTBN4 OSBP	2.68e-03	206	163	7	682
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA LRBA	2.79e-03	9	163	2	1230
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	KIFBP TTC21A GTF3C3 STIP1 IFIT3	3.88e-03	115	163	5	769
Coexpression	PUJANA_ATM_PCC_NETWORK	NUP50 SETD1A SF3B4 MCM6 RPS25 PFKFB4 TGM5 STAT5A JAK2 SYK PLCB4 PPIP5K2 DEK GP1BA DHX16 UBR2 GPR65 WAS ARFGEF2 XPNPEP1 PPWD1 IFIT3 ACTR3 ADAM22 CD1C RIF1 NXPH2 SMAD2 AURKB	3.98e-06	1394	215	29	M9585
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHS1 CHST9 TEX26 FGF14 CP NBEA SLC44A4 DNAI3 ADGB DNAH12	4.23e-08	195	216	10	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	PLCB4 UBR2 NBEA RFX7 IGF1R THRB LPP LRBA PAN3 VPS13B	5.12e-08	199	216	10	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Ciliated_cells-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	CHST9 SERPINB8 TEX26 FGF14 CP NBEA SLC44A4 ADGB DNAH12	1.71e-07	172	216	9	187ae91148d293537afc77e10da2b64302322224
ToppCell	10x3'2.3-week_14-16-Myeloid_DC-DC-DC_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HLA-DMB CHRNB4 SEL1L3 USP50 DPP4 PPM1G ADGB CD1C PEBP1	1.80e-07	173	216	9	a361474ad6f058bb3d3f9671bae697205535090b
ToppCell	(5)_Epithelial_cells-(5)_Glands_mucous\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ETV1 CHST9 SEL1L3 PLCB4 GP2 CP NBEA SLC44A4 NOSTRIN	2.52e-07	180	216	9	a4118adaf4b09e2ca01b662ed60e7bbf32a24d58
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHRNA3 CHRNB4 WNT16 SEL1L3 CACNA1H FGF14 PLXNA1 RNF208 ICAM5	3.03e-07	184	216	9	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHRNA3 CHRNB4 WNT16 SEL1L3 CACNA1H FGF14 PLXNA1 RNF208 ICAM5	3.03e-07	184	216	9	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|343B / Donor, Lineage, Cell class and subclass (all cells)	TTC21A PLEKHS1 CHST9 TEX26 DNAH10 SLC44A4 DNAI3 ADGB DNAH12	3.97e-07	190	216	9	169e600e95878000acf5d11f813f9028c7249646
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	TTC21A PLEKHS1 CHST9 TEX26 DNAH10 SLC44A4 DNAI3 ADGB DNAH12	3.97e-07	190	216	9	0cc36117c793d83cf4a1f66f47758a07d6712bd3
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DMB HLA-DQA2 WNT16 SEL1L3 SYK DNAH8 CD1C PLPP3 NXPH4	4.53e-07	193	216	9	7cc10e8b51091869d46e462f3214999e7b5348b1
ToppCell	remission-B_intermediate\|World / disease stage, cell group and cell class	HLA-DMB HLA-DQA2 WNT16 SEL1L3 SYK CR2 CD1C PLPP3 NXPH4	4.73e-07	194	216	9	78556b60c84c7bbffa1c8bf8684b3c427512da44
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DMB HLA-DQA2 WNT16 SEL1L3 SYK DNAH8 CD1C PLPP3 NXPH4	4.73e-07	194	216	9	2b61023a602d336ed0de174e9141046173db34e6
ToppCell	COVID-19_Mild-Lymphoid_B-B_intermediate\|COVID-19_Mild / Disease group, lineage and cell class	HLA-DMB HLA-DQA2 WNT16 SEL1L3 DNAH8 CR2 CD1C PLPP3 NXPH4	4.73e-07	194	216	9	bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DMB HLA-DQA2 WNT16 SEL1L3 SYK DNAH8 CD1C PLPP3 NXPH4	4.73e-07	194	216	9	f2486b19ac52a48d19f80b38a5536bee3dad745b
ToppCell	MS-IIF-Lymphocyte-B-B_intermediate\|IIF / Disease, condition lineage and cell class	HLA-DMB HLA-DQA2 TTC21A WNT16 SEL1L3 SYK DNAH8 CD1C RNASET2	5.61e-07	198	216	9	d6b533c5e1d55e13b1e87ce3dbacb1564bcdcc64
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate\|COVID-19_Mild / Disease, condition lineage and cell class	HLA-DMB HLA-DQA2 WNT16 SEL1L3 SYK DNAH8 CR2 CD1C NXPH4	5.85e-07	199	216	9	1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHST9 TBC1D8B TMEM184A FGF13 PLCB4 GP2 CP SLC44A4 NOSTRIN	6.10e-07	200	216	9	ed093626a9cac7531a2bf02f6e345c5e84b8c060
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA2 MRC2 SEL1L3 PLXNA1 MAPK8IP1 NBEA CD1C CCDC183	9.31e-07	155	216	8	d76a0f99ec35560d18820f9c92b69364ef2250e3
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHST9 RXRB SEL1L3 DPP4 CP SLC44A4 GPC6 NUDCD1	1.56e-06	166	216	8	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHST9 RXRB SEL1L3 DPP4 CP SLC44A4 GPC6 NUDCD1	1.56e-06	166	216	8	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHST9 RXRB SEL1L3 DPP4 CP SLC44A4 GPC6 NUDCD1	1.56e-06	166	216	8	4586d6725403f879fc96f67be579022587ce1906
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQGAP2 CHST9 CHRNA2 RASL10A SLC12A1 ICAM5 NXPH4 NXPH2	1.63e-06	167	216	8	95b3b5ba3414729f0460a26a0deca48de0cbe33e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQGAP2 CHST9 CHRNA2 RASL10A SLC12A1 ICAM5 NXPH4 NXPH2	1.63e-06	167	216	8	3dfec2fcc36caa6e394efae5e540a6fa28759977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQGAP2 CHST9 CHRNA2 RASL10A SLC12A1 ICAM5 NXPH4 NXPH2	1.63e-06	167	216	8	9480739587d51e67a281778b9bddd7b5ffc3ad92
ToppCell	Control-Epithelial_alveolar-AT_2-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ETV1 GNAZ RNF208 CP SLC44A4 DNAH1 ICAM5	1.69e-06	117	216	7	c6fc72608d56a389bcd87b5dc98a11e39b79bcb2
ToppCell	Ciliated_cells-A-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	PLEKHS1 CHST9 TEX26 GJB7 CP NBEA DNAI3 ADGB	1.86e-06	170	216	8	3d3a03979014df3a05c49be18010c6b94d786707
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	PLEKHS1 CHST9 FER1L6 FGF13 PLCB4 CP NBEA SLC44A4	2.22e-06	174	216	8	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 OTOGL JAG1 CACNA1H DNAH8 GPC6 LGR5 PLPP1	2.31e-06	175	216	8	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 OTOGL JAG1 CACNA1H DNAH8 GPC6 LGR5 PLPP1	2.31e-06	175	216	8	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DMB TTC21A FARP2 SEL1L3 SYK CR2 CD1C DNAH12	2.63e-06	178	216	8	812e261d9cbdc74fafe3c5c3422151c1cfacb22d
ToppCell	(5)_Glands_mucous\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ETV1 CHST9 SEL1L3 PLCB4 GP2 CP NBEA SLC44A4	2.63e-06	178	216	8	f0f19b0d78f2cc5df4d4c321a953a6e447d5114a
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	PLEKHS1 CHST9 FER1L6 FGF13 PLCB4 CP NBEA SLC44A4	2.74e-06	179	216	8	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TTC21A FGF14 DNAH10 SLC44A4 DNAI3 DNAH1 ADGB DNAH12	2.85e-06	180	216	8	92fb01b91261b3103454924cde56add337b41844
ToppCell	3'_v3-blood-Lymphocytic_B-Memory_B_cells\|blood / Manually curated celltypes from each tissue	HLA-DMB HLA-DQA2 WNT16 SEL1L3 DNAH8 CR2 CD1C NXPH4	3.23e-06	183	216	8	e3a418b745d7f040adf47be9e1043b945cae47ed
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB OTOGL USH2A DNAH10 STXBP5L DNAH1 GUCY2F MYO15A	3.36e-06	184	216	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB OTOGL USH2A DNAH10 STXBP5L DNAH1 GUCY2F MYO15A	3.36e-06	184	216	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB OTOGL USH2A DNAH10 STXBP5L DNAH1 GUCY2F MYO15A	3.36e-06	184	216	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	PLEKHS1 CHST9 FGF14 DNAH10 SLC44A4 ADGB ZNF19 DNAH12	3.78e-06	187	216	8	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	normal-na-Lymphocytic_B-B_atypical\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HLA-DMB NEB EPB41L4A WNT16 SEL1L3 SYK GNAZ PLPP3	3.94e-06	188	216	8	13653481d64c7a1ad833d738a3ee0bb9def7cec7
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DMB HLA-DQA2 SEL1L3 SYK DNAH8 CD1C PLPP3 NXPH4	3.94e-06	188	216	8	18d16e3f095a109b6a690f46fe7fcd5674c3636b
ToppCell	Epithelial_cells-Ciliated_cells-A\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	PLEKHS1 CHST9 FGF14 DNAH10 CP DNAI3 ADGB DNAH12	4.26e-06	190	216	8	549d813a8f23b175875e53347928941f143e236c
ToppCell	Ciliated_cells-A\|World / lung cells shred on cell class, cell subclass, sample id	PLEKHS1 CHST9 FGF14 DNAH10 CP DNAI3 ADGB DNAH12	4.26e-06	190	216	8	cd87731aaa7d252424f79cfce9f7931457f17bdf
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PLEKHS1 CHST9 TEX26 FGF14 DNAH10 CP SLC44A4 DNAH12	4.42e-06	191	216	8	9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHS1 CHST9 TEX26 FGF14 DNAH10 CP SLC44A4 DNAH12	4.42e-06	191	216	8	5129f778a9283bfac4ff322c21c5ca71da4b7174
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PLEKHS1 CHST9 TEX26 FGF14 DNAH10 CP SLC44A4 DNAH12	4.42e-06	191	216	8	df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PLEKHS1 CHST9 FGF14 DNAH10 SLC44A4 DNAI3 ADGB DNAH12	4.42e-06	191	216	8	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PLEKHS1 CHST9 FGF14 DNAH10 SLC44A4 DNAI3 ADGB DNAH12	4.42e-06	191	216	8	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	Control-Epithelial\|Control / Disease group,lineage and cell class （2021.01.30）	PLEKHS1 CHST9 TEX26 FGF14 DNAH10 CP SLC44A4 DNAH12	4.42e-06	191	216	8	b78547dae8328244a47c83346447bdd787efbcae
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PLEKHS1 CHST9 FGF14 DNAH10 SLC44A4 DNAI3 ADGB DNAH12	4.42e-06	191	216	8	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHS1 CHST9 TEX26 FGF14 DNAH10 CP SLC44A4 DNAH12	4.42e-06	191	216	8	c50d6a1a6209ed4157f7c00fc24d4ecb43790f44
ToppCell	BLOOD--(2)_Memory_B_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-DMB HLA-DQA2 WNT16 SEL1L3 SYK CD1C RNASET2 NXPH4	4.60e-06	192	216	8	9c3a4699f05f1a757d6e37d9f15675e970584cca
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL5 ETV1 ANKRD30B FGF13 PLXNA1 NXPH1 IL1R1 NXPH2	4.60e-06	192	216	8	342842378c20267c5044bdd622515e8b9f895623
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	PLEKHS1 CHST9 FGF14 DNAH10 SLC44A4 ADGB ZNF19 DNAH12	4.60e-06	192	216	8	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DMB HLA-DQA2 WNT16 SEL1L3 SYK DNAH8 CD1C PLPP3	4.96e-06	194	216	8	2b5eee7c3e52b63cce94205d18133c7704329c02
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-DMB HLA-DQA2 RPS25 FARP2 SEL1L3 SYK CR2 CD1C	4.96e-06	194	216	8	84aa5ca0356a06fce8799eb1bfa1c362bab34032
ToppCell	COVID-19_Convalescent-Lymphoid_B-B_intermediate\|COVID-19_Convalescent / Disease group, lineage and cell class	HLA-DMB WNT16 SEL1L3 SYK CR2 CD1C PLPP3 NXPH4	5.15e-06	195	216	8	b213f19dad4c8d5a6bf20cadb1135fb2bb0b40ee
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHS1 CHST9 EPB41L4A FER1L6 STMN4 FGF13 CP SLC44A4	5.15e-06	195	216	8	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	remission-B_intermediate\|remission / disease stage, cell group and cell class	HLA-DMB WNT16 SEL1L3 SYK CR2 CD1C PLPP3 NXPH4	5.15e-06	195	216	8	ee14d00eb5800fadd57c2304e9461534d8668674
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	IQGAP2 MYO10 CHST9 MRC2 GPC4 NACC2 PLPP3 LPP	5.55e-06	197	216	8	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	IQGAP2 MYO10 CHST9 MRC2 GPC4 NACC2 PLPP3 LPP	5.55e-06	197	216	8	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHS1 CHST9 FER1L6 TMEM184A FGF13 PLCB4 CP NBEA	5.76e-06	198	216	8	af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell	Severe-B_intermediate-6\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HLA-DMB SERPINB8 SYK DEK DNAH8 CD1C PLPP3 RNASET2	5.98e-06	199	216	8	bf6ebb63ab361d9d1946225894d7be433e9befab
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_intermediate\|COVID-19_Convalescent / Disease, condition lineage and cell class	HLA-DMB WNT16 SEL1L3 SYK CR2 CD1C RNASET2 NXPH4	6.21e-06	200	216	8	fdc0df661a34e0db3279334bdeebfdf60c85ef41
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TM9SF3 CHST9 SEL1L3 FGF13 PLCB4 CP SLC44A4 NOSTRIN	6.21e-06	200	216	8	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Neuron\|5w / Sample Type, Dataset, Time_group, and Cell type.	EPB41L4A CHRNA3 STMN4 SYK PLAU MAPK8IP1 NOSTRIN NXPH4	6.21e-06	200	216	8	6f3fe94107fa2a2ded4888780b36700cce48adb7
ToppCell	mild-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-DMB FARP2 WNT16 SEL1L3 SYK DNAH8 CR2 CD1C	6.21e-06	200	216	8	fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCell	mild-B_intermediate\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-DMB HLA-DQA2 WNT16 SEL1L3 DNAH8 CR2 CD1C NXPH4	6.21e-06	200	216	8	8e3132a1fe3708f725c5c4077878fb87bbea3678
ToppCell	Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))--\|Thalamus / BrainAtlas - Mouse McCarroll V32	CHRNA2 GP1BA CTCFL SLC12A1 RRH	8.32e-06	57	216	5	9614fe2acc6ee039383504f94bbe6d35aac27f25
ToppCell	Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))\|Thalamus / BrainAtlas - Mouse McCarroll V32	CHRNA2 GP1BA CTCFL SLC12A1 RRH	8.32e-06	57	216	5	309b3d48bfe215d7b581722c06d444b5b2ef6a30
ToppCell	Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))-\|Thalamus / BrainAtlas - Mouse McCarroll V32	CHRNA2 GP1BA CTCFL SLC12A1 RRH	8.32e-06	57	216	5	3c55a5598a7ea789500f2fbd35c79d2b97a3fc7d
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 PDZK1 PLXNA1 SELENOP ADAM22 P2RX4 MYO15A	1.34e-05	160	216	7	0544bc465af208da448858d6e174ff56f2e08a46
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHS1 CHST9 SGSM2 SEL1L3 CP NBEA SLC44A4	1.39e-05	161	216	7	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	facs-Trachea-18m-Hematologic-myeloid-granulocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEL1L3 SYK MMP8 GNAZ GP1BA GPR65 IL1RL1	1.39e-05	161	216	7	d1f2e5245c7c247b684f48f9f877e149a3ee7c06
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	EPB41L4A PLCB4 PPIP5K2 LANCL3 NXPH1 NACC2 NXPH2	1.39e-05	161	216	7	b81b346309f3facbfbebd91cae4c5b33c7bd24ef
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MCM6 NEB GPR65 SH3KBP1 ZAP70 NXPH4 VPS13B	1.51e-05	163	216	7	ed7319185c1ec384444309bb8be95691a0c2091c
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MCM6 NEB GPR65 SH3KBP1 ZAP70 NXPH4 VPS13B	1.51e-05	163	216	7	e6213900f56257fe38ac7852351bea0340294be0
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MCM6 NEB GPR65 SH3KBP1 ZAP70 NXPH4 VPS13B	1.51e-05	163	216	7	ef35d7ff09aa364734fea7fdaab6260c0a3fbf09
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	PLEKHS1 CHST9 FER1L6 FGF13 PLCB4 CP SLC44A4	1.57e-05	164	216	7	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	facs-Trachea-nan-18m-Myeloid-granulocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEL1L3 SYK MMP8 GNAZ GP1BA GPR65 IL1RL1	1.70e-05	166	216	7	7f8b4cf63c3e292ae421f111edaa4572717f4db1
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	NEB MRC2 PLCB4 GPC6 PLPP1 DPPA4 ZNF761	1.76e-05	167	216	7	b5d15773be32cd277125fd3b4056a8fefaefa5ec
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GPC4 FGF14 DNAI3 DNAH1 ADGB DNAH12 IFT122	1.83e-05	168	216	7	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TTC21A USP50 DNAH10 DNAH1 ADGB ZNF19 DNAH12	1.90e-05	169	216	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_4\|390C / Donor, Lineage, Cell class and subclass (all cells)	PLAU ARFGEF2 IFIT3 P2RX4 P2RY1 HHIPL1 CTSL	1.98e-05	170	216	7	439167e44a1bd5ac8e1e457351dd202ec968db46
ToppCell	ICU-NoSEP-Lymphocyte-B-B_intermediate\|ICU-NoSEP / Disease, Lineage and Cell Type	HLA-DQA2 RPS25 CHRNB4 WNT16 DNAH8 CD1C NXPH4	2.05e-05	171	216	7	c6b8578577aef4fe79c1a8ca778a068052f2c9d4
ToppCell	10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory\|Liver / Manually curated celltypes from each tissue	HLA-DMB HLA-DQA2 NEB WNT16 SYK DNAH8 CD1C	2.05e-05	171	216	7	eb47f4a09a630ed14a0898377039ed50ef7cc292
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STMN4 WNT16 CACNA1H FGF13 FGF14 PLXNA1 NXPH4	2.30e-05	174	216	7	742c73c9e090848b464323cb17579b86658c6792
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 DPP4 SELENOP LGR5 MOSPD1 THRB NXPH4	2.30e-05	174	216	7	268be5e7d2a18b866770b7cdb966c3958c7e6534
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SETD1A HLA-DQA2 NEB WNT16 SYK ABHD1 PLPP3	2.30e-05	174	216	7	59ccc5a82507463e0a316ba6286cb25ec1a4091b
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 DPP4 SELENOP LGR5 MOSPD1 THRB NXPH4	2.30e-05	174	216	7	4cdf2eedc28d88d18241ee390092426fdf849e79
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STMN4 WNT16 CACNA1H FGF13 FGF14 PLXNA1 NXPH4	2.30e-05	174	216	7	7fed9722e64c60843092f2ba71256e3043011ef6
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	WNT16 USH2A HHIPL1 CCDC183 NXPH2	2.45e-05	71	216	5	b0dbb059a7d05f825da608879b23aeebd6e9e61f
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	WNT16 USH2A HHIPL1 CCDC183 NXPH2	2.45e-05	71	216	5	149504ce72da0730074ea436fc2034ce8cb585d5
ToppCell	Severe-CD4+_T_activated\|Severe / Disease group and Cell class	TTC21A VWDE ARID5A USP50 NBEA IFIT3 PHF11	2.56e-05	177	216	7	a08f170f1143fcdd7d0842a54d9b807a4548f8b7
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	SERPINB8 SELENOP C2orf76 RASL10A FUCA1 TNFAIP6 CTSL	2.56e-05	177	216	7	52c2ba74a8605260a2623e7d151286e504ac4d19
ToppCell	Severe-B_memory-6\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HLA-DMB HLA-DQA2 SERPINB8 DEK DNAH8 CD1C RNASET2	2.56e-05	177	216	7	c4c3511782d5febd0c8b369eebe9355ad3c3bcf2
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	TTC21A VWDE ARID5A STIP1 NBEA IFIT3 PHF11	2.66e-05	178	216	7	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TTC21A MAPK8IP1 SLC44A4 DNAI3 DNAH1 ADGB DNAH12	2.66e-05	178	216	7	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	Ciliated_cells-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CHST9 FGF14 DNAH10 CP DNAI3 ADGB DNAH12	2.75e-05	179	216	7	0e6c22de2e3fb0ff23b3301863cf4011c5c59dff
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MCM6 ZNF518A JAK2 DEK C2orf76 RASL10A IL1RL1	2.75e-05	179	216	7	9dea57494d59abd6e8abf34e31faf53462ea0fa0
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TTC21A FGF14 DNAH10 SLC44A4 DNAI3 ADGB DNAH12	2.75e-05	179	216	7	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
Disease	colon adenocarcinoma (is_implicated_in)	STAT5A STAT5B JAK2 RNASET2	3.24e-05	26	209	4	DOID:234 (is_implicated_in)
Disease	smoking behavior, carbon monoxide exhalation measurement	CHRNA3 CHRNB4	4.99e-05	2	209	2	EFO_0004318, EFO_0006520
Disease	Intellectual Disability	SETD1A KIFBP HIVEP2 QRICH1 GTF3C3 MED13 NBEA RNASET2 WDR45B FUCA1 VPS53	3.73e-04	447	209	11	C3714756
Disease	eosinophil count	KIFBP HIVEP2 ARID5A STAT5B FARP2 JAK2 JAG1 CACNA1H GJB7 USP50 DHX16 UBR2 GPR65 XPNPEP1 ZAP70 MRO LPP PHF11 FUCA1 IL1RL1 NOSTRIN IL1R1 SMAD2	3.85e-04	1488	209	23	EFO_0004842
Disease	non-syndromic X-linked intellectual disability (is_implicated_in)	FGF13 ZMYM3	4.92e-04	5	209	2	DOID:0050776 (is_implicated_in)
Disease	Lupus Erythematosus, Discoid	C5 CR2	4.92e-04	5	209	2	C0024138
Disease	urate measurement, bone density	UBE4B FSTL5 TM9SF3 ETV1 QRICH1 USH2A DNAH8 NXPH1 SLC44A4 DNAH1 PLPP3 LPP NXPH2	5.07e-04	619	209	13	EFO_0003923, EFO_0004531
Disease	lung carcinoma	HLA-DMB CHRNA2 CHRNA3 TGM5 CHRNB4 UBR2 SLC44A4 RIF1 RNASET2 TNFAIP6 SMAD2	6.96e-04	482	209	11	EFO_0001071
Disease	peeling skin syndrome (is_implicated_in)	TGM5 SERPINB8	7.35e-04	6	209	2	DOID:0060283 (is_implicated_in)
Disease	age at diagnosis, coronary atherosclerosis measurement	ETV1 HHIPL1	7.35e-04	6	209	2	EFO_0004918, EFO_0007938
Disease	blood rubidium measurement	ARFGEF2 RIF1 TNFAIP6	8.08e-04	26	209	3	EFO_0021529
Disease	Mammary Neoplasms, Experimental	STAT5A MRC2 SELENOP YWHAZ RNPEP PEBP1	8.56e-04	155	209	6	C0024668
Disease	gastric adenocarcinoma (is_marker_for)	STAT5A STAT5B RNASET2	1.01e-03	28	209	3	DOID:3717 (is_marker_for)
Disease	hyperthyroidism (biomarker_via_orthology)	CP IGF1R CTSL	1.01e-03	28	209	3	DOID:7998 (biomarker_via_orthology)
Disease	reading and spelling ability	ZNF423 FSTL5 ETV1 NEB FGF14 ARFGEF2	1.22e-03	166	209	6	EFO_0005301
Disease	Crohn's disease	STAT5B JAK2 PLAU GPR65 PPM1G LPP RNASET2 PTCD2 IL1RL1 IL1R1	1.27e-03	441	209	10	EFO_0000384
Disease	NEPHRONOPHTHISIS 2	ZNF423 NXPH2	1.36e-03	8	209	2	C1865872
Disease	presubiculum volume	ZNF423 DPP4 WAS	1.36e-03	31	209	3	EFO_0009400
Disease	migraine disorder, glucose measurement	SGSM2 CACNA1H IGF1R	1.36e-03	31	209	3	EFO_0004468, MONDO_0005277
Disease	schizophrenia (implicated_via_orthology)	SETD1A HIVEP2 YWHAZ PPM1G	1.40e-03	68	209	4	DOID:5419 (implicated_via_orthology)
Disease	lung adenocarcinoma	CHRNA3 CHRNB4 UBE4A RFX7 RNASET2 HHIPL1	1.55e-03	174	209	6	EFO_0000571
Disease	osteoarthritis (is_marker_for)	JAG1 MMP8 IGF1R	1.94e-03	35	209	3	DOID:8398 (is_marker_for)
Disease	hippocampal CA3 volume	ABRAXAS2 JAG1 DPP4	2.11e-03	36	209	3	EFO_0009395
Disease	interleukin 1 receptor-like 1 measurement	IL1RL1 IL1R1	2.63e-03	11	209	2	EFO_0008168
Disease	urokinase-type plasminogen activator measurement	CHST9 PLAU	2.63e-03	11	209	2	EFO_0010803
Disease	diabetic nephropathy, type 2 diabetes mellitus	FSTL5 LPP	2.63e-03	11	209	2	EFO_0000401, MONDO_0005148
Disease	serum ST2 measurement	IL1RL1 IL1R1	2.63e-03	11	209	2	EFO_0005416
Disease	Lung Neoplasms	CHRNA2 CHRNA3 CHRNB4 STAT5A JAG1 SELENOP RNASET2	2.93e-03	265	209	7	C0024121
Disease	Malignant neoplasm of lung	CHRNA2 CHRNA3 CHRNB4 STAT5A JAG1 SELENOP RNASET2	2.99e-03	266	209	7	C0242379
Disease	Combined immunodeficiency	STAT5A STAT5B ZAP70	3.06e-03	41	209	3	C0494261
Disease	outer ear morphology trait	HIVEP2 LRBA	3.14e-03	12	209	2	EFO_0007664
Disease	Thromboembolism	JAK2 PLAU	3.14e-03	12	209	2	C0040038
Disease	Animal Mammary Neoplasms	STAT5A MRC2 SELENOP YWHAZ PEBP1	3.48e-03	142	209	5	C0024667
Disease	Mammary Carcinoma, Animal	STAT5A MRC2 SELENOP YWHAZ PEBP1	3.48e-03	142	209	5	C1257925
Disease	age at menarche	MYO10 CHRNA3 ZNF518A OSBP2 KBTBD2 IGF1R THRB NOSTRIN PAN3 SMAD2 EVI5L	3.58e-03	594	209	11	EFO_0004703
Disease	Common variable immunodeficiency	CR2 LRBA	3.70e-03	13	209	2	cv:C0009447
Disease	Neurodegeneration with brain iron accumulation	PANK2 CP	3.70e-03	13	209	2	cv:C2931845
Disease	Thrombus	PLAU GP1BA P2RY1	4.25e-03	46	209	3	C0087086
Disease	Malignant neoplasm of breast	PDZK1 PFKFB4 RXRB STAT5A OTOGL JAG1 DEK ARFGEF2 MOSPD1 NCOR1 RIF1 IGF1R GUCY2F ICAM5 LRBA VPS13B	4.29e-03	1074	209	16	C0006142
Disease	sulfate measurement	DNAI3 P2RY1	4.30e-03	14	209	2	EFO_0007864
Disease	Colorectal Carcinoma	ELOA2 FSTL5 ETV1 WNT16 DNAH8 SELENOP SLC44A4 LGR5 OSBP ICAM5 ZNF540 SMAD2	4.52e-03	702	209	12	C0009402
Disease	interleukin 18 receptor 1 measurement	IL1RL1 IL1R1	4.93e-03	15	209	2	EFO_0008178
Disease	brain edema (biomarker_via_orthology)	PLAU C5	4.93e-03	15	209	2	DOID:4724 (biomarker_via_orthology)
Disease	lung adenocarcinoma (is_implicated_in)	CHRNA3 CHRNB4 JAK2	5.08e-03	49	209	3	DOID:3910 (is_implicated_in)
Disease	hepatocellular carcinoma (implicated_via_orthology)	IQGAP2 CTSL SMAD2	5.08e-03	49	209	3	DOID:684 (implicated_via_orthology)
Disease	Thrombosis	PLAU GP1BA P2RY1	5.08e-03	49	209	3	C0040053
Disease	Craniofacial Abnormalities	MASP1 GPC4 GPC6 THRB SMAD2	5.17e-03	156	209	5	C0376634
Disease	cognitive inhibition measurement	HIVEP2 TGM5 USH2A	5.37e-03	50	209	3	EFO_0007969
Disease	lung small cell carcinoma (is_marker_for)	CHRNA3 CHRNB4	5.61e-03	16	209	2	DOID:5409 (is_marker_for)
Disease	congenital myasthenic syndrome (implicated_via_orthology)	CHRNA2 CHRNA3	5.61e-03	16	209	2	DOID:3635 (implicated_via_orthology)
Disease	cathepsin L1 measurement	ADGB CTSL	5.61e-03	16	209	2	EFO_0010619
Disease	corpus callosum volume measurement	ABRAXAS2 JAG1 WNT16 ZNF518B	5.65e-03	100	209	4	EFO_0010299
Disease	Vitiligo	FARP2 SLC44A4 LPP RNASET2	5.85e-03	101	209	4	EFO_0004208
Disease	Carcinomatosis	STAT5A MRC2 SELENOP YWHAZ PEBP1	6.21e-03	163	209	5	C0205699
Disease	Carcinoma, Spindle-Cell	STAT5A MRC2 SELENOP YWHAZ PEBP1	6.21e-03	163	209	5	C0205697
Disease	Undifferentiated carcinoma	STAT5A MRC2 SELENOP YWHAZ PEBP1	6.21e-03	163	209	5	C0205698
Disease	Anaplastic carcinoma	STAT5A MRC2 SELENOP YWHAZ PEBP1	6.21e-03	163	209	5	C0205696
Disease	heart disease (biomarker_via_orthology)	JAK2 CP	6.33e-03	17	209	2	DOID:114 (biomarker_via_orthology)
Disease	Eye Abnormalities	JAG1 IFT122	6.33e-03	17	209	2	C0015393
Disease	low density lipoprotein cholesterol measurement, body fat percentage	MCM6 DNAH10	6.33e-03	17	209	2	EFO_0004611, EFO_0007800
Disease	Antibody Deficiency Syndrome	C5 ZAP70	6.33e-03	17	209	2	C0003257
Disease	Acute myeloid leukemia	JAK2 LPP	6.33e-03	17	209	2	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	JAK2 LPP	6.33e-03	17	209	2	601626
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	MED13 RFX7	6.33e-03	17	209	2	DOID:0060307 (is_implicated_in)
Disease	Carcinoma	STAT5A MRC2 SELENOP YWHAZ PEBP1	6.37e-03	164	209	5	C0007097
Disease	susceptibility to common cold measurement	TPMT MYO5A ZNF423	6.66e-03	54	209	3	EFO_0008417
Disease	Peripheral Nervous System Diseases	MYO5A CACNA1H IGF1R	6.66e-03	54	209	3	C4721453

Protein segments in the cluster

Peptide	Gene	Start	Entry
PAIYKSACKIEVKYF	CHRNB4	146	P30926
SACKIEVKYFPFDQQ	CHRNB4	151	P30926
LDKFFQYDTLCESKP	NT5C1B	486	Q96P26
SCPDKLVLKAYQVKY	EVI5L	341	Q96CN4
YSESPYDTDCTKKFI	CCDC186	136	Q7Z3E2
PEAYKRLLSSFYCKG	ARID5A	236	Q03989
PCSKLFSFYDYASKV	ABRAXAS2	61	Q15018
NYECLPEATYQKEIK	ANKRD30B	886	Q9BXX2
CFDTPAVKYKYSALI	RNPEP	181	Q9H4A4
YHDANFIPTVYKCSK	CTCFL	536	Q8NI51
CLPVLSTDKFKTDFY	COPS6	266	Q7L5N1
QCSVDVYKKVGSLYP	DCTN1	676	Q14203
KSSCKIDVTYFPFDY	CHRNA3	156	P32297
YIFHKPSSYCLNFQK	ADGB	646	Q8N7X0
FKSKCKSLESYPCYQ	ADGB	966	Q8N7X0
KSLESYPCYQDEETK	ADGB	971	Q8N7X0
FYSFYKQATEGPCKL	ACBD5	71	Q5T8D3
SAPAKCFEYYEKTPL	ASB13	226	Q8WXK3
DKYFLPFELACQSKS	ARFGEF2	66	Q9Y6D5
TGYYLPKKFTQCNIE	ADAM22	406	Q9P0K1
DAYKRLCAFAYPNQK	DPPA4	116	Q7L190
NSKKYDCCAEIYPDV	CHRNA2	241	Q15822
IFYTKAPEADYLEAC	DHX16	581	O60231
IIYVLDPGFCKQKSY	DHX16	686	O60231
VKDAYIECTAYPDKN	DNAI3	206	Q8IWG1
CEEDYKNYKANPISS	C2orf76	111	Q3KRA6
YLLPFSKSICEFDYL	CCDC27	186	Q2M243
FVQSDYTEAYNPKIK	CLK1	296	P49759
CEPKEASYSLIRKYV	HP1BP3	271	Q5SSJ5
CDLTPIFKDYEKYLA	NUP50	181	Q9UKX7
AFYSVDYKLVQKVCP	NXPH2	236	O95156
FDYKLVQKVCPDYNF	NXPH4	286	O95158
KTVQDYLEKFYQLPS	MMP8	31	P22894
TTYLKSCIYDAKTDP	P2RX4	211	Q99571
YDFYLFKCPQSVKGR	QRICH1	706	Q2TAL8
QISKYCPLDLYSGNK	IPPK	176	Q9H8X2
YNSISYKTFLPKCIR	JAK2	201	O60674
SPPKATTKEAYCYEN	SLC34A3	576	Q8N130
STFYNPCIYVVANKK	RRH	286	O14718
KKFFACAPNYSYAAL	NUDCD1	496	Q96RS6
TLLVCGKKAYDYFQA	PDZK1	451	Q5T2W1
YLEDNIKTYCSEPEK	CP	231	P00450
KCALTKTGFQFYYLP	P2RY1	41	P47900
FEQPTLSCEKYLTYD	ELOA2	376	Q8IYF1
YLTFLPSADEIYDCK	HLA-DQA2	176	P01906
VYPYLCRALKTFVKD	MCM6	86	Q14566
CATYLKKLDSPGYAA	IFT122	811	Q9HBG6
LDDTDYCFPYLLVNK	HHIPL1	151	Q96JK4
IYCDAVPYLFKKVRA	L3MBTL2	406	Q969R5
SPCFNKYLLKFVSDY	MYO15A	2161	Q9UKN7
YLECVSKYTEQLKPF	GPC4	186	O75487
KQFVEYTCPTEDIYL	MAPK8IP1	696	Q9UQF2
PECINYYKFSSKSDV	SYK	541	P43405
VYTKESLYSFALKCL	KCNN1	131	Q92952
KCFLDHKTLYYDTDP	KAT5	321	Q92993
NYCSKDKIPIRKYAD	IGF1R	661	P08069
TYYKFEKLAIDPNTC	HS3ST5	206	Q8IZT8
KIVRLCVDDPKFYSY	PLXNA1	281	Q9UIW2
LAFYVQSTACKKGEY	ICAM5	856	Q9UMF0
KKYELRAPVAGTCYQ	PEBP1	156	P30086
EQPFKFSYGEKCLYN	ETV1	106	P50549
YFLDKAAEQLPYLKC	PFKFB4	401	Q16877
GYKIPLCKTLDQYFE	DNAH8	4151	Q96JB1
PECKFKESVFENYYV	FGF14	141	Q92915
YYNCEDKFKPQSLPD	FUCA1	276	P04066
CYATPTEDKADLVKY	GP2	401	P55259
NYFKYVPLKTQCTFI	DNAH12	1751	Q6ZR08
IKSDAYVCPLYKTSE	DNAH12	3036	Q6ZR08
VCYSPQAEKVYKLCS	KBTBD2	286	Q8IY47
YNPYEFALKFKVLCT	MOSPD1	41	Q9UJG1
FKLYCFLDTDNVPKD	MYO10	1786	Q9HD67
KAYLVSKKPQYLDTC	LANCL3	306	Q6ZV70
KKAYCEPCYINTLEQ	LPP	461	Q93052
NVDKDKPYLYCFRTS	LRBA	246	P50851
YCYKVFSSERLQDKK	MRC2	681	Q9UBG0
ATLFPKYREAYLKEC	KRR1	61	Q13601
FSKEAKYYQLRCSGP	DPP4	461	P27487
FQACSPYLKLKEEYS	MRO	201	Q9BYG7
GDKCNLKFVPYSYFS	OSBP	606	P22059
DRCQLKFLPYSYFSK	OSBP2	711	Q969R2
NLKDYKCVPQSLAYT	FSTL5	641	Q8N475
YYFENPADSEKCQKL	PANK2	361	Q9BZ23
CYKAVNSKDDLPYCL	PAN3	506	Q58A45
KEEKCTYADKYTQTP	CCSER2	756	Q9H7U1
RKAQDQDFYLCPIYK	DNAH1	4206	Q9P2D7
AVKERYSYVCPDLVK	ACTR3	226	P61158
STPEFYQVCHTKKDY	ACTR3	386	P61158
TPKDFTYCISFNKDL	HLA-DMB	36	P28068
EKNSKIYCPTIDLYN	IL1RL1	126	Q01638
YLECVSKYTDQLKPF	GPC6	186	Q9Y625
FNLEACKEYKPLIIY	GNAZ	61	P19086
CKEYKPLIIYNAIDS	GNAZ	66	P19086
NYCKRTPLYIDFKEI	BMP10	321	O95393
DKPAPKCEYFNKYSS	CR2	76	P20023
KCEYFNKYSSCPEPI	CR2	81	P20023
KEAPYFYNDTVTFKC	CR2	616	P20023
DYSKYPFEVQVKAGC	CD1C	106	P29017
AENKLDTKYPYVCHA	DCTD	71	P32321
ICKKVYENYPTYDLT	DEK	346	P35659
NSDYKRIVACASYKP	C5	1396	P01031
TACKPEIAYAYKVSI	C5	1551	P01031
CVNYELDNKISYPTF	GUCY2F	151	P51841
KQTCKKFSNPYSIEY	IFIT3	121	O14879
DLNSKLAYCEGKLTY	CCDC183	436	Q5T5S1
SVQCDNSDKFPVYKY	GP1BA	261	P07359
LTTYKSEIKYSCQEP	MASP1	386	P48740
LYTSELFTPECKFKE	FGF13	131	Q92913
YDGFSVPYLIKCDLK	GJB7	146	Q6PEY0
KDKPYLLYFNIFSCI	SLC44A4	81	Q53GD3
IKQYYVLCSSRDEKF	DDX19A	306	Q9NUU7
YKEFELQKVCYLPLN	FARP2	661	O94887
QPKSLDEALKYCNYV	CACNA1H	1641	O95180
PPCVAYDEKLQFYSK	DNAH10	1016	Q8IVF4
TLYFGIKFYAEDPCK	EPB41L4A	91	Q9HCS5
FQYLYLCPSEDKSKI	SCAF4	96	O95104
CYDFLPIKASDGKTY	IL1R1	371	P14778
YKFIVDYCEKHPEAA	KIFBP	576	Q96EK5
CYPDYTTRKTLAIKF	CPHXL	51	A0A1W2PPM1
TIAYTKLYCNLDKGD	LGR5	741	O75473
YAKKECSILYSDIFA	OTOGL	1131	Q3ZCN5
AFAICYKLNSPESFK	PTCD2	206	Q8WV60
LQPVKTKCTSDSYYQ	JAG1	941	P78504
TDCPYNKVYKNLKEF	NOSTRIN	6	Q8IVI9
YLPFEAKKPCVYFIS	FER1L6	571	Q2WGJ9
KLYCFYSPEEIEAKV	RTKN2	316	Q8IZC4
LVYDICSPDSFDYVK	RASL10A	91	Q92737
FTCKYADYISRDKPI	SENP2	551	Q9HC62
YNPLKYVCSDKISTG	USH2A	3376	O75445
SATHCFIDYPKKEDY	PLAU	221	P00749
IPKAEQSVAYKDFIY	SEL1L3	71	Q68CR1
QKPLYSSCLSVEKCY	RHBDD1	46	Q8TEB9
CTEYLSKSVGYKLPN	TDRD6	1191	O60522
YEKFYELTQKICPRT	PLCB4	206	Q15147
SKPQCRDAYKTYNIT	PRSS58	161	Q8IYP2
PKDAKLYSNRAACYT	STIP1	391	P31948
KFYCLPDNYEIIDSS	USP39	171	Q53GS9
ISFPCRSYKDYKTSL	LIPI	271	Q6XZB0
STDYKLVQKVCPDYN	NXPH1	246	P58417
FYCNDESIKYPLKTG	PLPP3	66	O14495
YENSKLDEVPKVYSC	RIF1	866	Q5UIP0
RYAFPCQVYAEKKEN	TMEM184A	321	Q6ZMB5
IIPECADKYYDALVK	IQGAP2	571	Q13576
INVDKDKPYLYCFRT	NBEA	271	Q8NFP9
VPDCVLYYYLTKKNE	NCOR1	471	O75376
RGVFCNDESIKYPYK	PLPP1	36	O14494
CAKYLPDIIKDQKAY	PPM1G	71	O15355
TDLYEFAKCKAYPTS	PPWD1	271	Q96BP3
TKSKDYCKVIFPYEA	SH3KBP1	266	Q96B97
NCSKYYEKEALLADP	SGSM2	151	O43147
PEYAIKFSVFEQCKN	SLC25A41	161	Q8N5S1
FFLYVYVTCKKPDVN	SLC12A1	636	Q13621
KYYTPVPCESATAKA	STAT5B	681	P51692
SYYKFLFNPKGECIR	WDR45B	316	Q5MNZ6
SCFLADPLNKSSYKY	STMN4	21	Q9H169
IKDFSYVYKPENCQI	MED13	896	Q9UHV7
DKATYDKLCKEVPNY	RPS25	51	P62851
TYDYKFPLEDNKIPC	SETD1A	1681	O15047
PDLYKGLTDCFLKTY	SLC25A2	41	Q9BXI2
FPYVEEAIKIAYCEK	SELENOP	156	P49908
LPDFKEYCQKFYQAE	SERPINB8	101	P50452
VEYKTCKNSEPFIIF	STXBP5L	311	Q9Y2K9
KVYASLETYCKQKYP	RXRB	466	P28702
DEVFSKYYTPVLAKA	STAT5A	676	P42229
AIFCYTKALKYEPTN	GTF3C3	236	Q9Y5Q9
CVTYYKAASPRTKID	ABHD1	301	Q96SE0
VFYYEILNSPEKACS	YWHAZ	176	P63104
ATEESCKYNPKYSVA	CTSL	206	P07711
EKVSKLCYPCLINYD	CHST9	351	Q7L1S5
YAPRGELYKELQKSC	AURKB	156	Q96GD4
YENEVCKQDYFIKSP	PLEKHS1	11	Q5SXH7
IKPSINYYQVADFKD	RNASET2	156	O00584
KVKDVPTAYCYTFTD	VWDE	416	Q8N2E2
KQCSKAFPDYSTYLR	ZNF823	251	P16415
YLISQDKAGKYCIPE	ZAP70	211	P43403
KYKLTYAEAKAVCEF	TNFAIP6	46	P98066
KPYECQECGKTFTLY	ZNF540	241	Q8NDQ6
PYKYEECDKAFNKFS	ZNF92	536	Q03936
QKPLECKECAKAFYY	ZNF599	476	Q96NL3
NPYKCEDSDKAYSFK	ZNF761	576	Q86XN6
PTAYEKECFTYVLKG	XPNPEP1	436	Q9NQW7
CEKVFYQSSKLIFPE	ZNF519	186	Q8TB69
KPYECSKYEKAFGTS	ZNF19	411	P17023
LQILYESCPKYKFIS	RNF208	171	Q9H0X6
KNIYKEIENYPTCYK	NAPG	181	Q99747
EIENYPTCYKKTIAQ	NAPG	186	Q99747
FGLPEKEKLVTYYSC	TBC1D8B	151	Q0IIM8
SCPDKGFTDKLFYIY	SLC27A4	231	Q6P1M0
YAFNLKKDEVCVNPY	SMAD2	151	Q15796
AKECSLDSDYFKYPL	UBE4B	531	O95155
IVKVYSYEFQKPSLC	SERINC4	371	A6NH21
FQTEEKKCKGYIPSY	THRB	86	P10828
YQFAYLCAKEKNPHT	ZBED8	96	Q8IZ13
AVCFVKDNPQKSYFI	WAS	71	P42768
KLYECKQCSKAFPDY	ZNF799	251	Q96GE5
KYIATDFTLKAFDCP	NRDC	661	O43847
FTAYCTLEKPVKFQE	SPTBN4	351	Q9H254
KCTYKNEVFTVFSLP	USP50	201	Q70EL3
KDDLLYVNKSPNYCV	WNT16	281	Q9UBV4
YVNKSPNYCVEDKKL	WNT16	286	Q9UBV4
KCIRPIKTTSFSDYY	UBE2U	166	Q5VVX9
SLPKQEVYDEYKSYC	RFX7	26	Q2KHR2
VCYNPPKTTYDDFSK	ZNF518A	1391	Q6AHZ1
ALCPKDVEYNVLYFA	PHF11	46	Q9UIL8
EAKTYPCKISYSQYS	TGM5	571	O43548
EKLDPYFLVCIAKEY	TTC21A	451	Q8NDW8
DAEKSNFTLCYDKYP	GPR65	161	Q8IYL9
AVLPSCADLFVYYKK	VPS53	466	Q5VIR6
ETYKYFSLPFCVGSK	TM9SF3	56	Q9HD45
RFKPEYKIADPICTY	SLC30A4	296	O14863
SYYSPQKVKSKEVLC	VPS13B	411	Q7Z7G8
PYKCDVCEKSFNYTS	ZFP62	616	Q8NB50
KIPELQDFSFKYGCY	TEX26	191	Q8N6G2
KVVYSCPYCSKRDFN	ZNF423	406	Q2M1K9
YLYSCFQRAKEEITK	UBE4A	176	Q14139
SKIPDIYDCIKYDVQ	PPIP5K2	721	O43314
KPYECKQCVKSFSYS	ZNF763	226	Q0D2J5
TNAKSYEEIIFGKYC	HIVEP2	416	P31629
YLYCLKPKNEFAEKA	TRAPPC13	251	A5PLN9
YELKPECAKEFNLYF	UBR2	831	Q8IWV8
QICEKYLPGYYSEKL	TBC1D10A	221	Q9BXI6
KKFQYLLCVLSYDPT	TPMT	176	P51580
KQCSKAFPVYSSYLR	ZNF44	276	P15621
YLCNRPITVSYAFKK	SF3B4	166	Q15427
PVKFYEFYLSKCPES	ZMYM3	1296	Q14202
YCDKCRFSTKDPLQY	ZNF518B	136	Q9C0D4
TIISLKPEDFAAYYC	IGKV1D-42	96	A0A075B6H8
IFYQLCASAKLPEFK	MYO5A	261	Q9Y4I1
AVKLYCQNFAPSFKE	NACC2	416	Q96BF6
YEKTKAKSINYCETP	NEB	391	P20929